These results suggest that ATG3 expression is notably increased in nasopharyngeal carcinoma, particularly in the EBV-positive group, indicating a potential role for EBV in modulating ATG3 levels (Figure 1). Here, ATG3 is linked to nasopharyngeal carcinoma.